BeStock  
Stocks › Biotechnology › TNGX

Tango Therapeutics TNGX

US equityMarket cap rank #2271Biotechnology
$21.73 −$0.98 (-4.32%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $22.00 +1.24%
Open$22.11
Prev close$22.71
Day range$21.63 – $23.05
Volume1.74M
Market cap$3.68B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±14.0%last 4 reports
Closed higher3 of 475% of the time
Best reaction+36.3%
Worst reaction0.0%

Stock move on the day after each report

+14.9%2025/Q1+4.9%2025/Q2+0.0%2025/Q3+36.3%2025/Q4
QuarterReport dateTimingImplied moveActual moveVersus implied
2025/Q45 Mar 2026Pre Market–+36.28%–
2025/Q34 Nov 2025Pre Market±18.4%+0.00%Within range
2025/Q25 Aug 2025Pre Market±42.9%+4.86%Within range
2025/Q112 May 2025Pre Market–+14.91%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$78.12M-655.1% YoY
Net profit-$68.39M-530.6% YoY
Diluted EPS-$0.39-400.0% YoY
Free cash flow-$37.20M-19.6% YoY
Operating cash flow-$37.14M

Revenue, last 8 quarters

$4.1MDec '24$5.4MMar '25$3.2MJun '25$53.8MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-37.7MDec '24$-39.9MMar '25$-38.9MJun '25$15.9MSep '25$-38.7MDec '25$-45.5MMar '26$-55.3MJun '26$-68.4MSep '26

Profitability & balance sheet

Return on equity-36.5%
Return on assets-33.5%
Return on invested capital-36.9%
Current ratio39.45
Liabilities / assets5.2%
Cash & investments$977.50M
Total debt$28.12M
Net cash (debt)$949.38M

Discussion

No comments yet — be the first to weigh in on TNGX.

Sign in to join the discussion.

Scroll to Top